UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001570
Receipt No. R000001893
Scientific Title A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma.
Date of disclosure of the study information 2008/12/18
Last modified on 2008/12/12 16:55:18

No. Disposal Last modified on Item of update
1 Insert 2008/12/12 16:57:14


Contact us.